These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37866092)

  • 1. FDA trial regulation of laboratory developed tests (LDTs): An academic medical center's experience with Mpox in-house testing.
    Caldera JR; Gray HK; Garner OB; Yang S
    J Clin Virol; 2023 Dec; 169():105611. PubMed ID: 37866092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Xpert™ Mpox PCR assay with oropharyngeal, anorectal, and cutaneous lesion swab specimens.
    Damhorst GL; McLendon K; Morales E; Solis ZM; Fitts E; Bowers HB; Sabino C; Sullivan J; Greenleaf M; Roback JD; Colasanti JA; Sheth AN; Titanji BK; Martin GS; Bassit L; Lam WA; Rao A
    J Clin Virol; 2024 Apr; 171():105659. PubMed ID: 38430669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary Regulatory Deviations and the Coronavirus Disease 2019 (COVID-19) PCR Labeling Update Study Indicate What Laboratory-Developed Test Regulation by the US Food and Drug Administration (FDA) Could Look Like.
    Marble HD; Bard AZ; Mizrachi MM; Lennerz JK
    J Mol Diagn; 2021 Oct; 23(10):1207-1217. PubMed ID: 34538703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing.
    Kim AS; Bartley AN; Bridge JA; Kamel-Reid S; Lazar AJ; Lindeman NI; Long TA; Merker JD; Rai AJ; Rimm DL; Rothberg PG; Vasalos P; Moncur JT
    JAMA Oncol; 2018 Jun; 4(6):838-841. PubMed ID: 29242895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the loss of Laboratory Developed Mass Spectrometry testing at a major academic medical center.
    Geno KA; Cervinski MA
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():63-66. PubMed ID: 36846026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA's proposed rule for the regulation of laboratory-developed tests.
    Miller MB; Watts ML; Samuel L
    J Clin Microbiol; 2024 Feb; 62(2):e0148823. PubMed ID: 38206042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Performance Evaluation of a Rapid Real-Time PCR Assay for Monkeypox Diagnosis: a Retrospective and Comparative Study.
    Peris MP; Clusa L; Alonso H; Escolar C; Fortuño B; Rezusta A; Milagro A
    Microbiol Spectr; 2023 Jun; 11(3):e0051023. PubMed ID: 37191553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. College of american pathologists proposal for the oversight of laboratory-developed tests.
    Vance GH
    Arch Pathol Lab Med; 2011 Nov; 135(11):1432-5. PubMed ID: 22032569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus.
    Coppens J; Vanroye F; Brosius I; Liesenborghs L; van Henten S; Vanbaelen T; Bracke S; Berens-Riha N; De Baetselier I; Kenyon C; Soentjens P; Florence E; Van Griensven J; Ariën KK; Jacobs BKM; Van den Bossche D; Van Esbroeck M; Vercauteren K;
    J Clin Virol; 2023 Feb; 159():105372. PubMed ID: 36608620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Mpox (Monkeypox) in patients undergoing STI screening in northern California, April-September 2022.
    Contag CA; Renfro ZT; Lu J; Shen S; Karan A; Solis D; Huang C; Sahoo MK; Yamamoto F; Jones MS; Lin J; Levy V; Pinsky BA
    J Clin Virol; 2023 Jul; 164():105493. PubMed ID: 37220710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory-Developed Tests: A Legislative and Regulatory Review.
    Genzen JR; Mohlman JS; Lynch JL; Squires MW; Weiss RL
    Clin Chem; 2017 Oct; 63(10):1575-1584. PubMed ID: 28687634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic targets for Mpox: the evidence to date.
    Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
    Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
    Huang DT; McCreary EK; Bariola JR; Wadas RJ; Kip KE; Marroquin OC; Koscumb S; Collins K; Shovel JA; Schmidhofer M; Wisniewski MK; Sullivan C; Yealy DM; Axe M; Nace DA; Haidar G; Khadem T; Linstrum K; Snyder GM; Seymour CW; Montgomery SK; McVerry BJ; Berry L; Berry S; Meyers R; Weissman A; Peck-Palmer OM; Wells A; Bart R; Albin DL; Minnier T; Angus DC
    Trials; 2021 May; 22(1):363. PubMed ID: 34034784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA.
    Mitchell SL; St George K; Rhoads DD; Butler-Wu SM; Dharmarha V; McNult P; Miller MB
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public Health Challenges in the Context of the Global Spread of Mpox Infections.
    Rahi M; Joy S; Sharma A
    Am J Trop Med Hyg; 2023 Apr; 108(4):641-645. PubMed ID: 36868216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status.
    Peaper DR; Rhoads DD; Sullivan KV; Couturier MR; Humphries RM; Martin IW; Nolte FS; Rowlinson MC; She RC; Simner PJ; Theel ES; Wojewoda CM
    J Clin Microbiol; 2021 Sep; 59(10):e0116721. PubMed ID: 34260276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mpox in Children: 3 Cases.
    Frantzis I; Ungar SP; Soma VL; Knutsen D; Mazo D; Zucker J
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38239109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-Counterpoint: The FDA Has a Role in Regulation of Laboratory-Developed Tests.
    Caliendo AM; Hanson KE
    J Clin Microbiol; 2016 Apr; 54(4):829-33. PubMed ID: 26791369
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.